| Targeted cancer therapy through antibody fragments-decorated nanomedicines A Alibakhshi, FA Kahaki, S Ahangarzadeh, H Yaghoobi, F Yarian, ... Journal of Controlled Release 268, 323-334, 2017 | 158 | 2017 |
| Novel and emerging mutations of SARS-CoV-2: Biomedical implications E Mohammadi, F Shafiee, K Shahzamani, MM Ranjbar, A Alibakhshi, ... Biomedicine & pharmacotherapy 139, 111599, 2021 | 46 | 2021 |
| Bicyclic peptides: types, synthesis and applications S Ahangarzadeh, MM Kanafi, S Hosseinzadeh, A Mokhtarzadeh, M Barati, ... Drug Discovery Today 24 (6), 1311-1319, 2019 | 36 | 2019 |
| Vaccine design and delivery approaches for COVID-19 K Shahzamani, F Mahmoudian, S Ahangarzadeh, MM Ranjbar, ... International Immunopharmacology 100, 1-13, 2021 | 35 | 2021 |
| An update on antiviral antibody-based biopharmaceuticals S Ahangarzadeh, Z Payandeh, R Arezumand, K Shahzamani, F Yarian, ... International immunopharmacology 86, 106760, 2020 | 24 | 2020 |
| Selection of single-chain variable fragments specific for Mycobacterium tuberculosis ESAT-6 antigen using ribosome display S Ahangarzadeh, M Bandehpour, B Kazemi Iranian Journal of Basic Medical Sciences 20 (3), 327, 2017 | 23 | 2017 |
| Current status of COVID-19 pandemic; characteristics, diagnosis, prevention, and treatment Z Nokhodian, MM Ranjbar, P Nasri, N Kassaian, P Shoaei, B Vakili, ... Journal of Research in Medical Sciences 25 (1), 101, 2020 | 21 | 2020 |
| Cloning, transformation and expression of human interferon α2b Gene in tobacco plant (Nicotiana tabacum cv. xanthi) S Ahangarzadeh, MH Daneshvar, H Rajabi-Memari, H Galehdari, ... Jundishapur journal of natural pharmaceutical products 7 (3), 111, 2012 | 21 | 2012 |
| Antibody‐drug therapeutic conjugates: Potential of antibody‐siRNAs in cancer therapy F Yarian, A Alibakhshi, S Eyvazi, R Arezumand, S Ahangarzadeh Journal of Cellular Physiology 234 (10), 16724-16738, 2019 | 19 | 2019 |
| Recent developments in antibody derivatives against colorectal cancer; A review S Ghani, S Bahrami, B Rafiee, S Eyvazi, F Yarian, S Ahangarzadeh, ... Life Sciences 265, 118791, 2021 | 18 | 2021 |
| In silico evaluation of the interactions among two selected single chain variable fragments (scFvs) and ESAT-6 antigen of Mycobacterium tuberculosis M Bandehpour, S Ahangarzadeh, F Yarian, A Lari, P Farnia Journal of Theoretical and Computational Chemistry 16 (08), 1750069, 2017 | 10 | 2017 |
| Bioinformatics evaluation of novel ribosome display-selected single chain variable fragment (scFv) structure with factor H binding protein through docking M Bandehpour, F Yarian, S Ahangarzadeh Journal of Theoretical and Computational Chemistry 16 (03), 1750021, 2017 | 9 | 2017 |
| Gene Editing-Based Technologies for Beta-hemoglobinopathies Treatment I Rahimmanesh, M Boshtam, S Kouhpayeh, H Khanahmad, A Dabiri, ... Biology 11 (6), 862, 2022 | 8 | 2022 |
| Computational design of a potential therapeutic peptide against spike protein of SARS-CoV-2 A Alibakhshi, S Ahangarzadeh, L Beikmohammadi, B Soltanmohammadi, ... Journal of Computational Biophysics and Chemistry 20 (04), 337-346, 2021 | 8 | 2021 |
| Virtual screening for the identification of potential candidate molecules against envelope (e) and membrane (m) proteins of SARS-CoV-2 A Alibakhshi, MM Ranjbar, SH Javanmard, F Yarian, S Ahangarzadeh Journal of Computational Biophysics and Chemistry 20 (03), 209-224, 2021 | 6 | 2021 |
| Bioinformatics prediction and experimental validation of VH antibody fragment interacting with Neisseria meningitidis factor H binding protein H Rafighdoust, S Ahangarzadeh, F Yarian, RA Taheri, A Lari, ... Iranian Journal of Basic Medical Sciences 23 (8), 1053, 2020 | 5 | 2020 |
| Development of polyepitopic immunogenic contrast against hepatitis C virus 1a-6a genotype by in silico approach Z Dehghan, A Lari, F Yarian, S Ahangarzadeh, Z Sharifnia, K Shahzamani, ... Biomedical and Biotechnology Research Journal (BBRJ) 4 (4), 355-364, 2020 | 4 | 2020 |
| Corrigendum to:“Novel and emerging mutations of SARS-CoV-2: Biomedical implications”[Biomed. Pharmacother. 139 (2021) 111599] E Mohammadi, F Shafiee, K Shahzamani, MM Ranjbar, A Alibakhshi, ... Biomedicine & Pharmacotherapy 140, 111723, 2021 | 2 | 2021 |
| Bioinformatic screening of compounds from Iranian lamiaceae family members against SARS-CoV-2 spike protein A Alibakhshi, S Gharibi, S Ahangarzadeh, F Yarian Letters in Drug Design & Discovery 20 (6), 684-698, 2023 | 1 | 2023 |
| Impact of selenium nanoparticle-enriched Lactobacilli feeding against Escherichia coli O157: H7 infection of BALB/c mice Z Esfandiari, B Vakili, S Ahangarzadeh, SN Esfahani, P Shoaei Probiotics and Antimicrobial Proteins, 1-12, 2023 | 1 | 2023 |
fatemeh yarianPhD in Medical Biotechnology, Fasa university of medical sciencesVerified email at fums.ac.ir
